EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Esophageal Hypervigilance and Mucosal Integrity Predict Symptom Outcomes in Reflux Patients With Normal Acid Exposure

Wei-Yi Lei, Jen-Hung Wang, Chandra Prakash Gyawali iD, Chih-Hsun Yi, Tso-Tsai Liu, Jui-Sheng Hung, Ming-Wun Wong, Chien-Lin Chen iD

Neurogastroenterology & Motility · 2025

DOI: 10.1111/nmo.70062 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurogastroenterology & Motility, 2025. Verfasst von Wei-Yi Lei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Alginates, Proton Pump Inhibitors, Anxiety. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Buddhist Tzu Chi Medical Foundation, Ministry of Science and Technology, Taiwan, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Managing esophageal symptoms with normal acid exposure is challenging, requiring focus on both physiological and psychological factors. However, no studies have explored how patients perceive symptom changes after using alginates or proton‐pump inhibitors (PPIs) in this context. This study examines the interrelationships among changes in reflux symptom severity, esophageal hypervigilance, and psychological distress in patients with normal esophageal acid exposure treated with either alginate suspension or PPIs.

Methods

We conducted a 2‐year prospective, randomized, open‐label study with patients displaying typical reflux symptoms but normal acid exposure, confirmed via ambulatory pH‐impedance monitoring. Participants completed validated questionnaires assessing esophageal hypervigilance and anxiety (EHAS), symptom severity, sleep quality, and depression at baseline and follow‐up to evaluate symptom changes and predictors between treatments.

Results

Among 146 patients (mean age: 47.9, 63% female), 75 received alginate and 71 PPI therapy. Improvements in questionnaire scores were significant across both treatments ( p < 0.001), with no differences between groups. However, only a few patients in both groups achieved a > 50% reduction in gastro‐esophageal reflux disease questionnaire (GERDQ) and global symptom severity (GSS) after treatment. Multivariable regression revealed that the reduction in esophageal hypervigilance and lower mean nocturnal baseline impedance (MNBI) were significant predictors of symptom improvement.

Conclusion

In reflux patients with normal acid exposure, neither PPIs nor alginates alone effectively improved symptoms, but reducing esophageal hypervigilance and anxiety led to better outcomes. Mucosal integrity and EHAS scores are independent predictors of treatment response. The EHAS is a useful tool for assessing treatment impact and guiding personalized care. A comprehensive approach addressing both psychological and physiological factors is essential, especially for those with normal acid levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxAlginatesProton Pump InhibitorsAnxietyEsophageal MucosaEsophagusHumansFemaleMaleMiddle AgedAdultProspective StudiesEsophageal pH MonitoringTreatment OutcomeSurveys and Questionnaires

Stichwörter der Autor:innen

esophageal hypervigilance and anxiety scalegastro‐esophageal reflux diseaseproton‐pump inhibitorsodium alginate

Substanzen

AlginatesProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan.
  • Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • Division of Gastroenterology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.

ORCID-Profile: Chandra Prakash Gyawali, Chien-Lin Chen

Förderung

  • Buddhist Tzu Chi Medical Foundation
  • Ministry of Science and Technology, Taiwan
  • National Science and Technology Council

Zitieren

APA

Lei, W. Y., Wang, J. H., Gyawali, C. P., Yi, C. H., Liu, T. T., Hung, J. S., Wong, M. W., & Chen, C. L. (2025). Esophageal Hypervigilance and Mucosal Integrity Predict Symptom Outcomes in Reflux Patients With Normal Acid Exposure. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.70062

Vancouver

Lei WY, Wang JH, Gyawali CP, Yi CH, Liu TT, Hung JS, et al. Esophageal Hypervigilance and Mucosal Integrity Predict Symptom Outcomes in Reflux Patients With Normal Acid Exposure. Neurogastroenterology & Motility. 2025. doi:10.1111/nmo.70062

BibTeX
@article{Lei2025,
  author = {Lei, Wei-Yi and Wang, Jen-Hung and Gyawali, Chandra Prakash and Yi, Chih-Hsun and Liu, Tso-Tsai and Hung, Jui-Sheng and Wong, Ming-Wun and Chen, Chien-Lin},
  title = {Esophageal Hypervigilance and Mucosal Integrity Predict Symptom Outcomes in Reflux Patients With Normal Acid Exposure},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  doi = {10.1111/nmo.70062}
}
Kostenlos starten →